All Articles

Actor Neal McDonough isn't just endorsing a wellness brand; he's on its leadership team. We analyze the market shift and what it means for consumers.

With a first-of-its-kind ethics badge, a new AI assistant aims to free up school leaders, turning administrative time into valuable teacher coaching.

A new partnership is turning Guatemala's $20B remittance market digital, moving beyond cash pickups to build a new foundation for financial inclusion.

NXG's latest distribution offers a high yield but a 100% return of capital. Is this a savvy tax strategy or a warning for income investors?

Traditional safety metrics are failing to prevent the worst accidents. A new report reveals why AI and a human-centric approach are now non-negotiable.

New data reveals a major shift in home improvement. Forget fleeting fads; 2026 is about turning your home into a high-functioning financial asset.

A complex derivative trade revealed in a UK filing shows how financial giants unwind bets as KKR's multi-billion-pound acquisition of Spectris plc nears its close.

In a landmark deal, Diginex's bid for AI leader Plan A signals major consolidation in the booming carbon accounting market, driven by new regulations.

Logitech's award-winning AI camera tech is more than an innovation; it's a strategic move to solve hybrid work's biggest engagement problems.

GlobalTech Corp. acquires a majority stake in Moda in Pelle, aiming to inject its AI into the premium footwear market. A bold move or a risky bet?

An Inc. award signals a major shift. See how Bunkerhill Health’s AI platform is moving beyond hype to automate real-world patient care at top hospitals.

A UK tech firm's takeover reveals a Wall Street play and the silicon foundation for the next generation of AI diagnostics and personalized medicine.

PFREUNDT's U.S. arm, PF Scales, sets up in Fort Wayne, aiming to disrupt the industrial weighing market with advanced mobile technology and a veteran leader.

Beyond the science, Latus Bio’s FDA clearance for a rare disease therapy reveals a masterclass in regulatory strategy set to reshape biotech investment.

Science 37’s award-winning model isn't just innovative; it's a regulated, nationwide virtual site that's rewriting the rules of drug development.

Aethlon Medical's Hemopurifier device targets inflammatory particles in Long COVID, opening a vast new market beyond its core oncology focus.

Ketel One is rewriting the spirits marketing playbook, blending celebrity, film festivals, and at-home kits to build an immersive brand ecosystem.

A financial tech giant rebrands as Acuity Analytics, armed with advanced AI. Its new target? The pharmaceutical sector. Here's why that matters.

Beyond a key executive hire, DNSFilter’s appointment of Rich Scott reveals a calculated plan to scale its AI-driven defenses in a rapidly evolving market.

Hologic is leveraging its Breast Cancer Index test to redefine treatment, moving from a niche tool to an essential diagnostic. Is this how you win?